Sequenom Announces Participation At The Bank Of America Merrill Lynch Health
SAN DIEGO, May 8, 2013
SAN DIEGO, May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the Bank of America
Merrill Lynch Health Care Conference at the Encore at the Wynn Hotel in Las
Vegas, NV on May 14-16, 2013.
Paul V. Maier, Chief Financial Officer, will present on Thursday, May 16, 2013
beginning at 12:00 p.m. PDT, to provide an overview of and update on the
Company. The presentation is expected to last approximately 30 minutes and
will be web cast live through the "Investors" section of the Sequenom website
at www.sequenom.com. An audio replay will be available for 30 days following
the initial presentation web cast.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.
SOURCE Sequenom, Inc.
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., 858-202-9028, email@example.com; or Jakob Jakobsen, Media
Contact, Chandler Chicco Agency, 310-309-1003,
Press spacebar to pause and continue. Press esc to stop.